3 months Premium FREE
No credit card. No commitment.
Abbott Laboratories
🇺🇸 ABT · NYSE/NASDAQ · US0028241000
Healthcare
USD 110.81 price at analysis
Scores
Key Metrics
Powered by EODHDP/E (TTM)
35.8
P/E (Price-to-Earnings)Shows how much investors pay for each $1 of profit. We display the TTM P/E (Trailing Twelve Months) which uses actual earnings from the last 4 quarters. This is more reliable than Forward P/E which uses analyst estimates.
Calculation: 110.81 ÷ 3.11 = 35.8
TTM period through: 2026-06-30
Forward P/E (estimated): 19.7
Based on analyst estimates
Reference: Provider P/E (Trailing): 35.4
Net Debt/EBITDA (TTM)
2.7x
Latest quarter: 15.2x
Net Debt / EBITDAA leverage ratio showing how many years of EBITDA (earnings before interest, taxes, depreciation, and amortization) it would take to repay net debt. EBITDA approximates operating cash generation. Lower ratios (e.g., <3x) are generally safer; higher (e.g., >5x) may indicate more financial risk.
TTM through: 2026-06-30
Latest quarter (2026-06-30): 15.2x
The quarterly value can spike when quarterly EBITDA is very low (e.g., one-time charges).
Quick guide: <2x manageable, >4x can be risky (sector-dependent).
ROE
10.6%
ROE (Return on Equity)A profitability measure: how much profit is generated from shareholders’ equity. Higher isn’t always better if it comes from high debt.
EV/EBITDA
18.3x
EV/EBITDAA valuation ratio that compares total business value (including debt) to EBITDA. Lower can mean cheaper, but context matters.
Dividend Summary
Powered by EODHDDividend Yield (Fwd)
2.85%
TTM: 2.26%
Dividend YieldThe Forward yield (Fwd) shows the next announced annual dividend / current price — what you'd earn going forward. The Trailing yield (TTM) in the tooltip shows dividends actually paid in the last 12 months. Forward is shown as primary because it reflects the company's current commitment to shareholders.
Forward Yield (estimated): 2.85%
Trailing Yield (TTM, last 12 months): 2.26%
Payout Ratio (Fwd)
81.2%
TTM: 78.5%
Payout RatioDividends as a percentage of earnings. The Forward payout (Fwd) uses the announced dividend divided by actual past earnings (TTM) — it tells you if the company can afford what it promised. Very high payouts can be risky, especially if profits fall.
Announced dividend / actual earnings (TTM)
Payout (Fwd): 81.2%
Payout (TTM): 78.5%
Cash Flow Payout (TTM): 43.0%
FCF Coverage (TTM): 2.05x
Growth Streak
8 yrs
Consec. increases
Div. Growth (5Y)
10.4%
Dividend History
EODHD Dividends API| Status | Type | Decl. Date | Ex-Div Date | Pay Date | Currency | Amount |
|---|---|---|---|---|---|---|
| Forecast* | Quarterly | — | 15 Jul 2027 | — | USD | 0.63 |
| Forecast* | Quarterly | — | 15 Apr 2027 | — | USD | 0.63 |
| Forecast* | Quarterly | — | 15 Jan 2027 | — | USD | 0.63 |
| Forecast* | Quarterly | — | 15 Oct 2026 | — | USD | 0.59 |
| Paid | Quarterly | 12 Jun 2026 | 15 Jul 2026 | 17 Aug 2026 | USD | 0.63 |
| Paid | Quarterly | 20 Feb 2026 | 15 Apr 2026 | 15 May 2026 | USD | 0.63 |
| Paid | Quarterly | 12 Dec 2025 | 15 Jan 2026 | 13 Feb 2026 | USD | 0.63 |
| Paid | Quarterly | 19 Sep 2025 | 15 Oct 2025 | 17 Nov 2025 | USD | 0.59 |
* Extrapolated from past dividend history. Not an official announcement — treat as an estimate, not a confirmed date or amount.
Summary
Abbott is an exceptionally high-quality healthcare leader with robust dividend growth and deep moats, but it currently trades at a steep premium (TTM P/E of 35.83). While legal headwinds present a temporary overhang, the valuation and 2.26% yield do not offer a compelling entry point today. Existing holders should maintain, but new buyers should wait for a substantial dip.
Sector Context
Abbott Laboratories operates globally across medical devices, diagnostics, nutrition, and generic pharmaceuticals. While the healthcare sector offers essential, recession-resistant cash flows ideal for dividend growth investing, major med-tech firms frequently navigate persistent litigation and regulatory burdens.
Temporary Opportunity Identified
Massive ongoing civil litigation (NEC infant formula) and pending IRS tax disputes create uncertainty, but the core healthcare business and cash flows remain heavily intact.
📊 Strategy Analysis
- • Exceptional cash flow dividend coverage at 2.05x with a safe 43.02% cash flow payout ratio.
- • Robust underlying business quality marked by a 10.5% historical dividend CAGR and highly essential medical device and diagnostics segments.
- • Recent Q2 earnings beat, guidance raises, and the closure of the DOJ's criminal probe into the Michigan formula plant underscore business resilience.
⚠ What to Watch
- • Severely elevated valuation with a TTM P/E of 35.83, far exceeding the optimal 8-15x DGI entry range.
- • Current TTM dividend yield of 2.26% falls short of the ideal 3.0% threshold for robust current income generation.
- • Significant structural liability overhang remains from thousands of ongoing NEC baby formula civil lawsuits (including a recent $495M verdict) and over $1.05B in contested IRS tax disputes.
📊 Historical Trends (10 Years)
Powered by EODHDThese charts show how key metrics have evolved over the past decade, helping you identify if the company is improving or deteriorating.
Debt Evolution (Net Debt / EBITDA)
Lower values are better. A declining trend indicates the company is reducing its debt (deleveraging).
Revenue & Earnings Growth
Consistent growth in revenueRevenue
The money a company brings in from selling its products or services. It’s the top line before costs. (blue) and earningsEarnings (Profit)
What’s left after expenses. Positive earnings mean the business made a profit; negative means a loss. (green) indicates a healthy business. Look for upward trends and recoveries after temporary dips.
Dividend Sustainability (FCF vs Dividends Paid)
Free cash flowFree Cash Flow
Cash left after the company pays for running the business and maintaining it. Often used to fund dividends, pay debt, or buy back shares. (FCFFCF (Free Cash Flow)
Short for Free Cash Flow: cash left after operating needs and maintenance spending., blue) should cover dividends paidDividends Paid
Cash the company paid out to shareholders. It’s not guaranteed and can change over time. (green). If dividends consistently exceed FCFFCF (Free Cash Flow)
Short for Free Cash Flow: cash left after operating needs and maintenance spending., the dividend may be at risk.
Analysis date: 2026-08-15
Disclaimer: This information is for educational purposes only. Not financial advice.